Deep-Learning Serial CT Prediction of Survival in Immunotherapy-Treated Non–Small Cell Lung Cancer

Key Points

• Survival outcomes were predicted more effectively with the deep-learning biomarker Serial CTRS.
• The deep-learning system outperformed traditional measurements like RECIST and TVC.
• This prognostic analysis involved patients undergoing immunotherapy for advanced non-small cell lung cancer.
• The study highlights a potential shift towards automated assessment methods in cancer care.